Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer

BJU International

Volumn 99, Issue 5, 2007, Pages 1041-1046

  Lattouf, Jean Baptiste ^a   Grubb III, Robert L ^a   Lee, S Justin ^a   Bjurlin, Marc A ^a   Albert, Paul ^a   Singh, Anurag K ^a   Ocak, Iclal ^a   Choyke, Peter ^a   Coleman, Jonathan A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; MRI; Prostate biopsy; Prostate cancer; Ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACINAR CELL; ADULT; AGED; ARTICLE; CANCER RISK; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; FAMILY HISTORY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; BIOPSY, NEEDLE; DIGITAL RECTAL EXAMINATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 34247152458     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06690.x     Document Type: Article

References (20)

1. Zackrisson B, Aus G, Bergdahl S et al. The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable. J Urol 2004; 171: 1500-3
2. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166: 86-92
3. Fleshner N, Klotz L. Role of 'saturation biopsy' in the detection of prostate cancer among difficult diagnostic cases. Urology 2002; 60: 93-7
4. Amsellem-Ouazana D, Younes P, Conquy S et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 2005; 47: 582-6
5. Beyersdorff D, Taupitz M, Winkelmann B et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002; 224: 701-6
6. Perrotti M, Han KR, Epstein RE et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study. J Urol 1999; 162: 1314-7
7. Yuen JS, Thng CH, Tan PH et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 2004; 171: 1482-6
8. Ikonen S, Kivisaari L, Tervahartiala P, Vehmas T, Taari K, Rannikko S. Prostatic MR imaging. Accuracy in differentiating cancer from other prostatic disorders. Acta Radiol 2001; 42: 348-54
9. White S, Hricak H, Forstner R et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995; 195: 385-90
10. Mullerad M, Hricak H, Kuroiwa K et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005; 174: 2158-63
11. Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005; 53: 249-55
12. Padhani AR, Gapinski CJ, Macvicar DA et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000; 55: 99-109
13. Futterer JJ, Heijmink SW, Scheenen TW et al. Prostate cancer: local staging at 3-T endorectal MR imaging - early experience. Radiology 2006; 238: 184-91
14. Littrup PJ, Williams CR, Egglin TK, Kane RA. Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques. Radiology 1991; 179: 49-53
15. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22
16. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman & Hall, 1993
17. Bono AV, Celato N, Cova V, Salvadore M, Chinetti S, Novario R. Microvessel density in prostate carcinoma. Prostate Cancer Prostatic Dis 2002; 5: 123-7
18. Shih SJ, Dall'Era MA, Westphal JR et al. Elements regulating angiogenesis and correlative microvessel density in benign hyperplastic and malignant prostate tissue. Prostate Cancer Prostatic Dis 2003; 6: 131-7
19. Siegal JA, Yu E, Brawer MK. Topography of neovascularity in human prostate carcinoma. Cancer 1995; 75: 2545-51
20. Wefer AE, Hricak H, Vigneron DB et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000; 164: 400-4